MX9202034A - Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes. - Google Patents

Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes.

Info

Publication number
MX9202034A
MX9202034A MX9202034A MX9202034A MX9202034A MX 9202034 A MX9202034 A MX 9202034A MX 9202034 A MX9202034 A MX 9202034A MX 9202034 A MX9202034 A MX 9202034A MX 9202034 A MX9202034 A MX 9202034A
Authority
MX
Mexico
Prior art keywords
ruminants
mastitis
macrolide
antibiotics
prevention
Prior art date
Application number
MX9202034A
Other languages
English (en)
Inventor
Tats Matsuoka
David Glen Mcclary
Earl Eugene Ose
Thomas Donald Thomson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9202034A publication Critical patent/MX9202034A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
MX9202034A 1991-05-02 1992-04-30 Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes. MX9202034A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69472091A 1991-05-02 1991-05-02

Publications (1)

Publication Number Publication Date
MX9202034A true MX9202034A (es) 1992-11-01

Family

ID=24790008

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9202034A MX9202034A (es) 1991-05-02 1992-04-30 Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes.

Country Status (14)

Country Link
EP (1) EP0512779A1 (es)
JP (1) JPH05186355A (es)
KR (1) KR920021142A (es)
CN (1) CN1066269A (es)
AU (1) AU652443B2 (es)
CA (1) CA2067520A1 (es)
CZ (1) CZ133592A3 (es)
IE (1) IE921419A1 (es)
IL (1) IL101749A0 (es)
MX (1) MX9202034A (es)
NO (1) NO921720L (es)
NZ (1) NZ242557A (es)
TW (1) TW221028B (es)
ZA (1) ZA923125B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
CN103923141B (zh) * 2014-04-21 2016-04-27 西南大学 一种依托替米考星的合成方法
CN106692137A (zh) * 2016-12-27 2017-05-24 王�华 一种急性乳腺炎的乳导管治疗方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
FR2646081A1 (es) * 1989-04-20 1990-10-26 Adir

Also Published As

Publication number Publication date
TW221028B (es) 1994-02-11
AU1593792A (en) 1992-11-05
IE921419A1 (en) 1992-11-04
CN1066269A (zh) 1992-11-18
AU652443B2 (en) 1994-08-25
JPH05186355A (ja) 1993-07-27
IL101749A0 (en) 1992-12-30
ZA923125B (en) 1993-10-29
EP0512779A1 (en) 1992-11-11
NZ242557A (en) 1993-10-26
CZ133592A3 (en) 1993-01-13
NO921720L (no) 1992-11-03
KR920021142A (ko) 1992-12-18
NO921720D0 (no) 1992-04-30
CA2067520A1 (en) 1992-11-03

Similar Documents

Publication Publication Date Title
DE68913792T2 (de) Synergistische antimikrobielle Zusammensetzung.
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
FI923273A0 (fi) Med dubbelminne foersett multiprocessorsystem.
IT1237483B (it) Composizione orale antibatterica antiplacca.
MX9201969A (es) Formulacion de tableta optimizada.
MX9207008A (es) Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia.
DZ1559A1 (fr) Compositions pharmaceutiques.
NL192926B (nl) Cefalosporinederivaat met antibacteriële werking, en farmaceutisch preparaat daaruit.
MX9202034A (es) Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes.
MX9202507A (es) Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
EP0268135A3 (en) Coccidiocidal agents
MX9201258A (es) Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
MX9204286A (es) Agentes para el tratamiento de semillas.
ES2196769T3 (es) Uso topico de loperamide para el tratamiento de infecciones microbianas.
ES2019583B3 (es) Composicion para el tratamiento de infecciones.
MX9204338A (es) Metodos de tratamiento con antimicrobianos y composiciones antimicrobianas.
MX9202147A (es) Composicion de peroxido-poli propileno.
ES1017890Y (es) Dispositivo para el tratamiento de uneros.
ES1017044Y (es) Silo de enfriamiento perfeccionado.
ES1019136Y (es) Cesta perfeccionada para el juego de cesta-punta.
MX9200555A (es) Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil.
MX9204323A (es) Procedimiento para la preparacion de derivados de taxano.
MX9203089A (es) Composicion para el tratamiento de esquisofrenia.
MX9204485A (es) Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
NZ335361A (en) Anthelmintic formulation comprisinga compound selected fromn the avermectin or milbeycin series and an inorganic selenium salt